Cramer makes the call on viewers' favorite stocks.   Read More

This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate.  The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess.  Here are the biggest S&P Health Care gainers and losers over while the debate has waged on.   Read More

Markets opened higher on Wednesday, helped by a positive jobs data. Where should investors be looking right now? Bernard Lirola, fund manager of the Needham Aggressive Growth Fund, shared his favorite stock picks.   Read More

Despite what you’ve heard, the public option might not be off the table after all.    Read More

Despite an early pullback in the stock market, 26 stocks in the S&P 500 reached new 52-week highs so far in the trading session.   Read More

As the earnings season gets underway, a total of 85 S&P stocks or about 17% of companies in the S&P 500 reached new 52-week highs so far in today's trading session.     Read More

Worries over health care reform have caused the sector to be underowned, but there are still opportunities for investors looking to take advantage of the low prices, said Charles Boorady of Citigroup and Arthur Henderson of Jeffries & Co.    Read More

Hint: The real story in the sector has nothing to do with President Obama.    Read More

Investors were going gaga for Google (GOOG) five years ago today. In one of the most anticipated IPOs over the past decade, the Internet search company priced nearly 20 million shares at $85 per share, raising $1.7 billion dollars through an auction of its shares.    Read More

So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate.  This week there are over 20 more healthcare companies reporting.  Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.   Read More